Home

Jeffrey L. Ives

CIK 1614096 · last filed 2026-06-05

Jeffrey L. Ives is a corporate insider who has filed 35 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for ABOS, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$1.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $152.1K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$152.1K

Companies

2

Total Filings

35

Lifetime Open-Market Net

-$1.06M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ABOS Director 48,300 $3.15 $152.1K -$272.3K 7 2026-06-05
Tvardi Therapeutics, Inc. (CARA) Delisted Director 5,513 $15.96 $88.0K -$785.5K 27 2024-06-06

Recent Filings

35 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-05 ABOS Grant (A) +35,500 $0 EDGAR
2025-06-05 ABOS Grant (A) +12,800 $0 EDGAR
2024-06-10 ABOS Grant (A) — $0 EDGAR
2024-06-06 Tvardi Therapeutics, Inc. (CARA) Delisted Grant (A) +150,647 $0 EDGAR
2023-08-18 ABOS Mixed — -$240.8K EDGAR
2023-08-17 ABOS Notice (144) −41,949 -$272.3K EDGAR
2023-06-07 ABOS Grant (A) — $0 EDGAR
2023-06-05 Tvardi Therapeutics, Inc. (CARA) Delisted Grant (A) +32,362 $0 EDGAR
2022-07-19 Tvardi Therapeutics, Inc. (CARA) Delisted Sell (S) −3,600 -$32.6K EDGAR
2022-06-17 ABOS Grant (A) — $0 EDGAR
Showing 1–10 of 35
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.